Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02124733 · ClinicalTrials.gov registry record · Phase 3
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
A Phase 3 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
NCT02124733 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 23 participants.
The verdict
NCT02124733, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is being done to compare a new, continuous illumination regimen of ALA-PDT (Aminolevulinate-Photodynamic Therapy) to a conventional regimen for treatment of actinic keratoses. The hypothesis is that the continuous illumination approach will be less painful, but equally efficacious, as the old regimen.
Interventions
- PROCEDURE Aminolevulinic acid based photodynamic therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02124733
The ClinicalTrials.gov registry entry for NCT02124733 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aminolevulinic acid based photodynamic therapy is the first listed.
NCT02124733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02124733 about?
NCT02124733 is a clinical study titled "Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses". This study is being done to compare a new, continuous illumination regimen of ALA-PDT (Aminolevulinate-Photodynamic Therapy) to a conventional regimen for treatment of actinic keratoses. The hypothesis is that the continuous illumination approach will be less painful, but equally efficacious, as the...
What is the current status of trial NCT02124733?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2014-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02124733?
The interventions under investigation include: Aminolevulinic acid based photodynamic therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02124733?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.